World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
35748
World Ranking
9260
National Ranking
4779

Overview

Gregory T. Everson is affiliated with the University of Colorado Denver in the United States. Their research focus lies primarily in the field of Medicine, with a strong emphasis on Hepatology. Within this domain, their work covers several subfields including Epidemiology, Surgery, Pharmacology, and Oncology.

The scientist's research interests align closely with topics such as Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment, and Organ Transplantation Techniques and Outcomes. Additional areas of study include Drug-Induced Hepatotoxicity and Protection, Hepatitis C virus research, Hepatocellular Carcinoma Treatment and Prognosis, and Liver Diseases and Immunity.

Gregory T. Everson has contributed extensively to academic publications, with notable recent papers including:

  • Predicting clinical decompensation in patients with cirrhosis using the Hepquant-SHUNT test (2021), published in Alimentary Pharmacology & Therapeutics
  • Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation (2020), published in Hepatology
  • HepQuant SHUNT Detects Portal Hypertension in Early Stages of Clinically Compensated Chronic Liver Disease (2021), published in Clinical Gastroenterology and Hepatology
  • The within-individual reproducibility of the disease severity index from the HepQuant SHUNT test of liver function and physiology (2021), published in Translational research
  • Advances in noninvasive measurement of liver function and physiology: The HepQuant DuO test (2024), published in Basic & Clinical Pharmacology & Toxicology

The scientist frequently collaborates with colleagues such as Michael P. McRae, Steve M. Helmke, Joanne C. Imperial, and John Kittelson.

Gregory T. Everson's work appears regularly in prominent publication venues including:

  • Alimentary Pharmacology & Therapeutics
  • UNC Libraries
  • Gastroenterology
  • Translational research
  • Gastro Hep Advances

This extensive publication record reflects a sustained engagement with research that addresses various dimensions of liver disease, its diagnosis, treatment, and the physiological assessment of liver function.

Best Publications

  • Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

    Mark S. Sulkowski;David F. Gardiner;Maribel Rodriguez-Torres;K. Rajender Reddy

  • Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options

    Ira M. Jacobson;Stuart C. Gordon;Kris V. Kowdley;Eric M. Yoshida

  • Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection

    John G. McHutchison;Gregory T. Everson;Stuart C. Gordon;Ira M. Jacobson

  • Response-guided Telaprevir Combination Treatment for Hepatitis C Virus Infection

    Kenneth K.E. Sherman;Steven S.L. Flamm;Nezam N.H. Afdhal;David Nelson

  • Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

    Michael Charlton;Gregory T. Everson;Steven L. Flamm;Princy Kumar

  • Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1

    Anna S. Lok;David F. Gardiner;Eric Lawitz;Claudia Martorell

  • Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

    Anna S. Lok;Leonard B. Seeff;Timothy R. Morgan;Adrian M. di Bisceglie

  • Prospective, Randomized, Multicenter, Controlled Trial of a Bioartificial Liver in Treating Acute Liver Failure

    Achilles A. Demetriou;Robert S. Brown;Ronald W. Busuttil;Jeffrey Fair

  • Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.

    Mitchell L. Shiffman;Adrian M. Di Bisceglie;Karen L. Lindsay;Chihiro Morishima

  • Adult-to-adult transplantation of the right hepatic lobe from a living donor

    James F Trotter;Michael Wachs;Gregory T Everson;Igal Kam

  • Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

    Adrian M. Di Bisceglie;Mitchell L. Shiffman;Gregory T. Everson;Karen L. Lindsay

  • Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases

    Michael R. Lucey;Kimberly A. Brown;Gregory T. Everson;John J. Fung

  • Efficacy and safety of pegylated (40-kd) interferon α-2a compared with interferon α-2a in noncirrhotic patients with chronic hepatitis C☆

    K. Rajender Reddy;Teresa L. Wright;Paul J. Pockros;Mitchell Shiffman

  • Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy

    Gregory T. Everson;James Trotter;Lisa Forman;Marcelo Kugelmas

  • A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction

    Gregory T. Everson;Dan Z. Braverman;Michael L. Johnson;Fred Kern

  • Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial

    Leonard B. Seeff;Gregory T. Everson;Timothy R. Morgan;Teresa M. Curto

  • Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial☆

    Adrian M. Di Bisceglie;Richard K. Sterling;Raymond T. Chung;James E. Everhart

  • All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study

    Michael Peter Manns;Stanislas B Pol;Ira M Jacobson;Patrick M Marcellin

  • Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT‐C cohort

    Anna S F Lok;Marc G. Ghany;Zachary D. Goodman;Elizabeth C. Wright

  • Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study

    Michael P. Curry;Xavier Forns;Raymond T. Chung;Norah A. Terrault

Frequent Co-Authors

Mitchell L. Shiffman
Mitchell L. Shiffman Bon Secours Health System
Timothy R. Morgan
Timothy R. Morgan California State University, Long Beach
Marc G. Ghany
Marc G. Ghany National Institutes of Health
William M. Lee
William M. Lee The University of Texas Southwestern Medical Center
Jules L. Dienstag
Jules L. Dienstag Harvard University
Adrian M. Di Bisceglie
Adrian M. Di Bisceglie Saint Louis University
Herbert L. Bonkovsky
Herbert L. Bonkovsky Wake Forest University
Chihiro Morishima
Chihiro Morishima University of Washington
James E. Everhart
James E. Everhart National Institutes of Health
Anna S.F. Lok
Anna S.F. Lok University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students seeking flexible routes into healthcare, online degrees offer convenient and accelerated options. Many registered nurses are choosing online rn to bsn programs no clinicals, allowing them to advance their credentials without the demands of on-site clinical hours.

If you aspire to reach higher nursing roles, you might consider dnp online programs. These doctoral degrees are designed for working professionals, with some identified as the dnp program without clinical hours, offering a streamlined path to a terminal degree in nursing.

For those at the start of their nursing journey, there are fast lpn program options online. These programs enable rapid entry into the practical nursing workforce and can be a stepping stone to further advancement in healthcare.

Whether aiming for initial licensure or career progression, online nursing degrees provide versatile options that cater to various needs and professional goals. Researching programs carefully will help you find the path best suited to your aspirations.

Best Scientists Citing Gregory T. Everson

Trending Scientists

Recently Published Articles